Table 1.

Demographics (Period 1)

		Proposed biosimilar/reference (N = 92)	Reference/proposed biosimilar (N = 92 a )
Age (years)	Mean	26.30	27.10
	SD	6.77	7.90
Sex n (%)	Female	34 (37)	33 (36)
	Male	58 (63)	59 (64)
BMI (kg m–2)	Mean	24.22	23.51
	SD	2.25	2.03

^a93 subjects were randomized in this group but one did not receive study medication

N, number of subjects in treatment group; BMI, body mass index; n, number of subjects with characteristic